伊兰科将以每股9.25美元的价格收购Kindred Biosciences的所有未发行股票,即约4.4亿美元,根据30天的平均水平,溢价为52%。
交易为开发阶段带来了三款潜在的重磅炸弹,补充了现有的管道,并增强了单克隆抗体的研发能力。
到2...查看全文
Kindred Biosciences(KIN)2021-06-16 19:42
$Kindred Biosciences(KIN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001561743-21-000046 Act: 34 Size: 1 MB 网页链接查看全文
Linktu2021-04-02 07:41
$Kindred Biosciences(KIN)$ 公告第一个利好出来了真好,现在还只是股东加持,加持的原因就不用说了,审批早已经提交上去,估计很快批下来了,先不说几家大兽医药公司想要收购它,就冲着这个宠物0死亡的药,批下来是肯定没问题的,接下来是暴涨,然后在新的股价上进行一轮新的调整,在量产时,股价...查看全文
Kindred Biosciences(KIN)2021-05-12 04:42
$Kindred Biosciences(KIN)$ 8-K Current report, items 1.01, 2.02, and 9.01 Accession Number: 0001561743-21-000035 Act: 34 Size: 340 KB 网页链接查看全文
Kindred Biosciences(KIN)2021-05-12 04:18
$Kindred Biosciences(KIN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001561743-21-000036 Act: 34 Size: 7 MB 网页链接查看全文
Linktu2021-04-21 12:48
$Kindred Biosciences(KIN)$
Kindred Biosciences 揭示了其长期作用白细胞介素-31 抗体 PK 研究的积极结果
工程抗体显示半衰期增长高达三倍
旧金山,2021 年 4 月 20 日/PRNewswire/ -- Kindred Biosciences, Inc.专注于拯救和改善宠物生命的生物制药公司(纳斯达克:KIN)今天公布了...查看全文
格隆汇6月16日丨Kindred Biosciences(KIN.US)现报9.18美元,大涨44.79%,暂成交2.15亿美元,最新市值4.16亿美元,换手率高达71.76%。 此前,全球第四大动物保健公司礼来动保将以每股9.25美元的价格收购生物制药公司Kindred Biosciences。 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000092 Size: 36 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000091 Size: 27 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000090 Size: 36 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000089 Size: 34 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000088 Size: 28 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000087 Size: 27 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000086 Size: 20 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000085 Size: 15 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000084 Size: 5 KB 网页链接
$Kindred Biosciences(KIN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001250853-21-000083 Size: 5 KB 网页链接